HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jen-Ping Chang Chiung-Lun Kao Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, J.-P. Articles by Kao, C.-L. Search for Related Content PubMed PubMed Citation Articles by Chang, J.-P. Articles by Kao, C.-L. Related Collections Valve disease

Ann Thorac Surg 2003;76:694-697
© 2003 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Mitral valve repair in uremic congestive cardiomyopathy

^a Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital at Kaohsiung, Taiwan, People’s Republic of China

Accepted for publication March 28, 2003.

^* Address reprint requests to Dr Chang, Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital at Kaohsiung, 123, Ta-Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan, R.O.C., People’s Republic of China.
e-mail: c9112772{at}adm.cgmh.org.tw

BACKGROUND: There is limited reported experience on mitral valve repair in patients with chronic renal failure. This study was designed to evaluate the outcomes of mitral valve repair in patients suffering from congestive heart failure as a result of uremic cardiomyopathy and severe mitral regurgitation requiring chronic hemodialysis.

METHODS: From 1995 to 2002, 5 women, ages 41 to 64 years (53 ± 8 years), with uremic congestive cardiomyopathy and end-stage renal disease on chronic hemodialysis who underwent mitral valve repair for severe mitral regurgitation were identified retrospectively and followed for clinical and echocardiographic outcomes. The preoperative New York Heart Association functional class was 3.8 ± 0.45.

RESULTS: All patients had good results immediately after surgical mitral valve repair with no more than mild mitral regurgitation. During the follow-up at an average of 22.4 ± 14.9 months (range, 3 to 41 months) postoperatively, all patients returned to New York Heart Association functional class I. Neither mitral calcification nor increasing peak transmitral gradient (or decreasing mitral valve orifice area) was notable by two-dimensional echocardiography. No reoperation was required.

CONCLUSIONS: Although accelerated calcification of the repaired mitral valve and high incidence of failure of the reconstruction had been reported in patients with end-stage renal disease, based on our experience we advocate mitral valve repair when this can be safely performed, especially in patients with uremic congestive cardiomyopathy, in view of the added advantage of retaining the native valve in such patients.

This article has been cited by other articles:

				K. Toda, K. Taniguchi, H. Matsue, and K. Yoshida Novel adjunct to surgery for end-stage cardiomyopathy receiving hemodialysis Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 272 - 274. [Abstract] [Full Text] [PDF]